Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:
- Novo Nordisk, Eli Lilly and Sanofi Face Lawsuit Over Insulin Prices. Becker’s Hospital Review. February 18, 2019.
The three big insulin makers, Novo Nordisk, Eli Lilly and Sanofi, must face a lawsuit that claims they gouged diabetes patients with the price of their lifesaving medications.
2) Cyberattack on NRC Health Sparks Privacy Concerns. CNBC. February 20, 2020.
NRC Health, a company that works with 75 percent of the 200 largest U.S. hospital chains, was hit with a cyberattack on Feb. 11, 2020. The attack sparked concerns about the security of patient health information stored on NRC Health’s servers.
3) 3rd Circuit Revives Antitrust Claims Against Johnson & Johnson over Remicade Pricing. Reuters. February 21, 2020.
A U.S. appeals court revived a lawsuit by Walgreen Co and Kroger Co accusing Johnson & Johnson of unlawfully restricting access to lower-cost biosimilar versions of its drug Remicade.
4) FDA Approves Eli Lilly’s Trulicity for Diabetic Patients. Reuters. February 21, 2020.
Eli Lilly and Co said on Friday the U.S. Food and Drug Administration has approved Trulicity for reducing cardiovascular risk factors in type 2 diabetic patients.
5) Michigan ACO Executive Sentenced to Prison for Stealing Medicare Bonus. Becker’s Hospital Review. February 21, 2020.
The former CEO of Southeast Michigan Accountable Care in Dearborn was sentenced Feb. 19 to three years in prison after pleading guilty to wire fraud in connection with his theft of more than $3.4 million from the ACO.
Do you have questions about healthcare issues? We can help. For assistance, CLICK HERE.
Get “News You Can Use” delivered directly to your e-mail inbox. Click here to Subscribe.
